11 Most Oversold Penny Stocks to Buy Now

Page 8 of 10

3. Iovance Biotherapeutics, Inc. (NASDAQ:IOVA)

Price: $2.60

YTD Performance: -66.62%

Analyst Upside Potential: 188.46%

Number of Hedge Fund Holders: 37

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) is one of the Most Oversold Penny Stocks to Buy Now. On August 18, Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) announced receiving conditional approval for Amtagvi from Health Canada. Amtagvi is a tumor-derived T cell immunotherapy designed for adult patients with unresectable or metastatic melanoma.

Management noted that this is the first approval of Amtagvi outside the United States and marks a major milestone for the company. Moreover, the company also plans to open its first Canadian treatment center soon and expand availability to other countries with high rates of advanced melanoma.

Although the approval is conditional and is dependent on further clinical trials confirming its benefits.

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) develops and delivers tumor-infiltrating lymphocyte therapies for solid tumor cancers.

Page 8 of 10